Drug Safety Alert: IPC flags adverse drug reaction linked to Tacrolimus
The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of July, has revealed that Tacrolimus, an immunosuppressive drug can lead to adverse drug reaction named Gingival Hypertrophy.This came after preliminary analysis of Adverse Drug Reactions (ADRs) from the Pharmacovigilance Programme of India (PvPI) database.For more details, check out the...
The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of July, has revealed that Tacrolimus, an immunosuppressive drug can lead to adverse drug reaction named Gingival Hypertrophy.
This came after preliminary analysis of Adverse Drug Reactions (ADRs) from the Pharmacovigilance Programme of India (PvPI) database.
For more details, check out the full story on the link below:
Drug Safety Alert: IPC Flags Adverse Drug Reaction Linked To Tacrolimus
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd